RT @mdmanishshah: Sneak peek: From buzzwords to breakthroughs, Dr. Sarah Rutherford (@DrSarahRuth) & I discuss impactful #cancer research i….

RT @mdmanishshah: Honored to host CancerCast for @WeillCornell .There is so much to learn and so much to talk about! .Available on Apple P….

Join millions who have switched to Grok.

Dr. Joseph Scandura describes how the investigational drug rusfertide works for #PolycythemiaVera. He led the #ClinicalTrial @WeillCornell looking at the effectiveness of this treatment, with results presented during the plenary session today at #ASCO25:

RT @WCMNYPJCTO: Clinical research @WeillCornell @nyphospital is dedicated to innovating, inspiring and transforming lives. On #ClinicalTria….

RT @WeillCornell: This year’s World Cancer Day theme is "United by Unique." Our collaborative approach to cancer care ensures patients rece….

#Research led by @WeillCornell Silver MPN Center team members, including research program assistant Neville Lee, Jr., evaluated the newer interferon ROPEG to the more commonly used PEG in #PolycythemiaVera patients: #ASH24

From #ASH24: @WeillCornell team members evaluated the #MPN Personalized Risk Calculator (MPN-PRC) in determining overall survival, progression to #Myelofibrosis, and leukemic transformation in patients with #PolycythemiaVera

Additional artificial intelligence (#AI) #research conducted by @WeillCornell & @StonyBrookMed team members and shared at #ASH24 found that certain cell traits are shared amongst #MyeloproliferativeNeoplasm patients with worse outcomes:

Dr. @GhaithAbuZeinah breaks down #research findings that determined DNMT3A mutations do not affect outcomes in patients with #PolycythemiaVera treated with interferon-alpha (IFN): #ASH24

Researchers from @WeillCornell and @StonyBrookMed utilized a form of artificial intelligence (#AI) to detect mutations in bone marrow biopsy images from patients with #MyleoproliferativeNeoplasms: #ASH24

Dr. Joseph Scandura explains #research from the @WeillCornell Silver MPN Center that was shared at #ASH24 looking at the impact of pulmonary hypertension on #MyleoproliferativeNeoplasm patients, particularly those with #PolythemiaVera:

.@WeillCornell Silver MPN Center research program assistant Katie Erdos was involved with #research comparing a combination treatment to ruxolitinib alone in patients with #Myelofibrosis: #ASH24

Third-year HemOnc fellow Dr. Franco Castillo Tokumori (@CTFrancoMD) shared @WeillCornell @nyphospital led #research that was featured at #ASH24 on an #MPN Fitness model developed by the Silver MPN Center:

Dr. Daniel Choi wrote a summary of @WeillCornell MPN Center #research assessing lymphoid development and production in patients with #MyeloproliferativeNeoplasms (#MPNs) and how the JAK2V617F mutation has an impact:

RT @JohnPLeonardMD: It was great to have @WCM_MeyerCancer Director and #Immunotherapy expert Dr. Jedd Wolchok (@wolchokj) on @WeillCornell….

Join @DrEllenRitchie at the @LLSusa National Virtual #BloodCancer Conference where she’ll be speaking to patients, caregivers, and loved ones about #MyeloproliferativeNeoplasms (#MPNs). Register and learn more here:

RT @CTFrancoMD: Thank you for the recognition! I appreciate the support (@DrJoeScandura Dan Choi @GhaithAbuZeinah @WCMSilverMPNCtr) and wil….

Dr. @GhaithAbuZeinah and colleagues wrote a letter to @BloodCancerJnl describing how the risk for #EssentialThromboychtemia (ET) related events can be predicted using available clinical data:

RT @JohnPLeonardMD: Our @ASCO #CancerCast tradition continues! Dr. Manish Shah (@mdmanishshah) joined me for our annual episode where we de….

#ASCO24 was a great chance to connect with colleagues from all over the world and nice to run into some @WeillCornell @nyphospital familiar faces!